NCT00486135 Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT00485719 Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors Status COMPLETED Phase PHASE1
NCT00481637 Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients Status COMPLETED Phase N/A
NCT00479583 Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX Status COMPLETED Phase PHASE1
NCT00475917 A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT00473616 Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan Status TERMINATED Phase PHASE1
NCT00463814 AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT00463060 Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00459823 A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours Status SUSPENDED Phase PHASE1
NCT00454090 AZD8330 First Time in Man in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00450645 Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis Status UNKNOWN Phase PHASE4
NCT00447226 Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists Status TERMINATED Phase PHASE2